Institutional Fund
Baker Bros. Advisors LP
New York, NYCIK 12635085 filings on record
Portfolio Value
$17.42B
Q1 2026
Holdings
84
Reported positions
New Buys
8
Opened this quarter
QoQ Change
+2.4%
from $17.01B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Incyte Corp16.6%
- Beone Medicines Ltd15.0%
- Insmed Inc7.0%
- Madrigal Pharmaceuticals Inc6.4%
- Acadia Pharmaceuticals Inc5.5%
- Revolution Medicines Inc5.3%
- Other44.2%
Portfolio Holdings
84 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Incyte Corp | 30.74M | $2.89B | 16.6% | +421 | Added |
| 2 | Beone Medicines Ltd | 8.80M | $2.61B | 15.0% | 0 | Held |
| 3 | Insmed Inc | 7.42M | $1.21B | 7.0% | +828.4K | Added |
| 4 | Madrigal Pharmaceuticals Inc | 2.14M | $1.12B | 6.4% | 0 | Held |
| 5 | Acadia Pharmaceuticals Inc | 42.90M | $954.88M | 5.5% | 0 | Held |
| 6 | Revolution Medicines Inc | 9.56M | $929.26M | 5.3% | +100.0K | Added |
| 7 | Celcuity Inc | 7.92M | $903.51M | 5.2% | 0 | Held |
| 8 | Kodiak Sciences Inc | 19.92M | $759.32M | 4.4% | 0 | Held |
| 9 | Kymera Therapeutics Inc | 8.66M | $721.06M | 4.1% | 0 | Held |
| 10 | Summit Therapeutics Inc | 36.39M | $689.97M | 4.0% | 0 | Held |
74 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio